A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...

DelveInsight's “Vitiligo Treatment Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in ...

The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK ...

Herpes zoster (HZ) is common in older people, with a lifetime risk of 25%. The main risk factors are advanced age and immunosuppression. People with a rheumatic and musculoskeletal disease have an ...

Frailty is common in rheumatic diseases and linked to worse outcomes. Early screening and targeted prevention can improve ...

Explore causes, symptoms and diagnosis of Giant Cell Arteritis and Temporal Arteritis including headache, vision loss and jaw pain linked to artery inflammation ...

Giant cell arteritis (GCA) is the most common form of vasculitis in the older adult population. There are variable clinical presentations of this entity and no perfect diagnostic test, often ...

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck.

Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) overview. Giant cell arteritis (GCA) is a form of vasculitis, a group of disorders that cause inflammation of blood vessels ...